HB 77 Illinois House · 104th Regular Session

CONTROLLED SUB-XYLAZINE

Summary
Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides that notwithstanding the scheduling of xylazine as a Schedule III controlled substance, xylazine shall not be considered a controlled substance when: (1) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species of a drug containing xylazine that has been approved by the U.S. Food and Drug Administration; (2) used by licensed Illinois veterinarians dispensing or prescribing for, or administering to, a nonhuman species that is permissible under the Federal Food, Drug, and Cosmetic Act; (3) manufactured, distributed, or used as an active pharmaceutical ingredient for manufacturing an animal drug approved under the Federal Food, Drug, and Cosmetic Act; (4) used by a licensed certified euthanasia technician employed by a certified euthanasia agency; or (5) used by a wildlife biologist engaged in legal or authorized fieldwork under the indirect supervision of a veterinarian.
Bill status in committee 1 of 4 stages cleared
Introduction
Dec 2024
Committee Review
Floor Vote
Governor
Introduced Dec 16, 2024 Last action Mar 21, 2025
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
13
Key actions
1
Committee
6
Amendments
1
Mar 21, 2025
Committee
House Committee Amendment No. 1 Rule 19(c) / Re-referred to Rules Committee
lower
Mar 21, 2025
Committee
Rule 19(a) / Re-referred to Rules Committee
lower
Feb 25, 2025
Lower · Passed
House Committee Amendment No. 1 Rules Refers to Judiciary - Criminal Committee
lower
Feb 18, 2025
Committee
House Committee Amendment No. 1 Referred to Rules Committee
lower
Feb 18, 2025
Introduced
House Committee Amendment No. 1 Filed with Clerk by Rep. Jackie Haas
lower
Feb 4, 2025
Committee
Assigned to Judiciary - Criminal Committee
lower
Jan 9, 2025
Committee
Referred to Rules Committee
lower
1 primary · 4 co-sponsors

Sponsors